Unveiling 4 Analyst Insights On Theravance Biopharma
Unveiling 4 Analyst Insights On Theravance Biopharma
揭示四个有关theravance biopharma的分析师见解
A clear picture of Theravance Biopharma's...Across the recent three months, 4 analysts have shared their insights on Theravance Biopharma (NASDAQ:TBPH), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中，有4个分析师对Theravance Biopharma（纳斯达克股票代码：TBPH）发表了自己的见解，表达了从看好到看淡的各种意见。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.25, with a high estimate of $15.00 and a low estimate of $9.00. A 18.33% drop is evident in the current average compared to the previous average price target of $15.00.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.25, with a high estimate of $15.00 and a low estimate of $9.00. A 18.33% drop is evident in the current average compared to the previous average price target of $15.00.
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
A clear picture of Theravance Biopharma's...
通过对最近分析...
登录免费看全文
登录/注册